OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
011170$81900.0059

Lotte Chemical Corp

Commodity ChemicalsVerified

Lotte Chemical Corp has a liquidity position that is characterized by a current ratio of 1.04, indicating that the company has just enough current assets to cover its current liabilities. The company's liquidity is further reflected in its cash and equivalents of 1,863,911,971,920 KRW, which is significantly lower than its long-term debt of 9,614,456,156,320 KRW, resulting in a negative net cash position. The company's profitability is currently negative, with a return on equity of -16.19% and a return on assets of -6.55%, which are below the industry norms for commodity chemicals. The operating income is negative at -20,171,221,119,600 KRW, and the net income is also negative at -2,037,135,124,080 KRW, indicating a challenging financial performance. Lotte Chemical Corp's revenue is concentrated in the commodity chemicals segment, with no disclosed geographic breakdown in the provided data. The company's revenue concentration in a single business segment may expose it to higher risk if market conditions for commodity chemicals deteriorate. The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year. However, the negative operating and net income suggest that the company may face challenges in achieving growth in the near term. The risk assessment for Lotte Chemical Corp indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to manage its liquidity carefully to avoid financial distress. There is no mention of dilution potential in the basic shares outstanding, as both basic and diluted shares are the same at 42,167,147. Recent events related to Lotte Chemical Corp include analyst estimates that suggest a range of price targets from 55,000 KRW to 165,000 KRW, with a mean recommendation of 2.24, indicating a generally positive outlook from analysts. The mean price target is 105,235.29 KRW, and the median is 110,000 KRW, suggesting that analysts expect the stock to appreciate from its current market price of 81,900 KRW.

30-day price · 011170-9800.00 (-10.7%)
Low$77100.00High$119500.00Close$81800.00As of22 May, 00:00 UTC
Profile
CompanyLotte Chemical Corp
Ticker011170.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Lotte Chemical Corp is a South Korean company engaged in the production and sale of commodity chemicals, including petrochemicals and related products.

Classification. Lotte Chemical Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Lotte Chemical Corp has a liquidity position that is characterized by a current ratio of 1.04, indicating that the company has just enough current assets to cover its current liabilities. The company's liquidity is further reflected in its cash and equivalents of 1,863,911,971,920 KRW, which is significantly lower than its long-term debt of 9,614,456,156,320 KRW, resulting in a negative net cash position. The company's profitability is currently negative, with a return on equity of -16.19% and a return on assets of -6.55%, which are below the industry norms for commodity chemicals. The operating income is negative at -20,171,221,119,600 KRW, and the net income is also negative at -2,037,135,124,080 KRW, indicating a challenging financial performance. Lotte Chemical Corp's revenue is concentrated in the commodity chemicals segment, with no disclosed geographic breakdown in the provided data. The company's revenue concentration in a single business segment may expose it to higher risk if market conditions for commodity chemicals deteriorate. The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year. However, the negative operating and net income suggest that the company may face challenges in achieving growth in the near term. The risk assessment for Lotte Chemical Corp indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to manage its liquidity carefully to avoid financial distress. There is no mention of dilution potential in the basic shares outstanding, as both basic and diluted shares are the same at 42,167,147. Recent events related to Lotte Chemical Corp include analyst estimates that suggest a range of price targets from 55,000 KRW to 165,000 KRW, with a mean recommendation of 2.24, indicating a generally positive outlook from analysts. The mean price target is 105,235.29 KRW, and the median is 110,000 KRW, suggesting that analysts expect the stock to appreciate from its current market price of 81,900 KRW.
Key takeaways
  • Lotte Chemical Corp is currently experiencing negative profitability, with a return on equity of -16.19% and a return on assets of -6.55%.
  • The company's liquidity position is medium, with a current ratio of 1.04 and a negative net cash position after subtracting total debt.
  • Analysts have a generally positive outlook on the company, with a mean recommendation of 2.24 and a range of price targets from 55,000 KRW to 165,000 KRW.
  • The company's revenue is concentrated in the commodity chemicals segment, which may expose it to higher risk if market conditions for this segment deteriorate.
  • The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$18.48T
Gross profit$262.02B
Operating income-$2.02T
Net income-$2.04T
R&D
SG&A
D&A
SBC
Operating cash flow$488.93B
CapEx-$1.63T
Free cash flow-$2.97T
Total assets$31.12T
Total liabilities$18.53T
Total equity$12.58T
Cash & equivalents$1.86T
Long-term debt$9.61T
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$18.48T-$2.02T-$2.04T-$2.97T
FY-1$19.89T-$1.96T-$1.71T-$3.03T
FY-2$19.95T-$429.42B-$50.04B-$2.70T
FY-3$22.28T-$833.90B$61.59B-$1.97T
FY-4$18.12T$1.59T$1.33T$1.31T
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$31.12T$12.58T$1.86T
FY-1$34.55T$14.35T$1.61T
FY-2$33.48T$15.54T$2.08T
FY-3$26.78T$14.45T$2.76T
FY-4$22.86T$14.40T$1.60T
PeriodOCFCapExFCFSBC
FY0$488.93B-$1.63T-$2.97T
FY-1$1.54T-$2.26T-$3.03T
FY-2$789.53B-$3.65T-$2.70T
FY-3-$167.47B-$2.60T-$1.97T
FY-4$1.49T-$775.34B$1.31T
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$4.71T-$1.51T-$1.32T-$1.64T
FQ-1$4.79T-$132.84B-$118.02B-$193.48B
FQ-2$4.20T-$244.92B-$404.50B-$729.99B
FQ-3$4.90T-$126.60B-$190.83B-$340.78B
FQ-4$4.79T-$1.28T-$1.07T-$1.22T
FQ-5$5.08T-$417.42B-$447.33B-$748.16B
FQ-6$5.09T-$121.29B-$109.39B-$420.18B
FQ-7$5.09T-$135.28B-$85.49B-$454.83B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$31.12T$12.58T$1.86T
FQ-1$33.67T$13.46T$2.72T
FQ-2$33.45T$13.35T$3.23T
FQ-3$34.76T$14.41T$3.09T
FQ-4$34.55T$14.35T$1.61T
FQ-5$34.49T$15.03T$1.91T
FQ-6$35.71T$15.62T$2.64T
FQ-7$35.13T$15.61T$2.95T
PeriodOCFCapExFCFSBC
FQ0$488.93B-$1.63T-$1.64T
FQ-1$498.07B-$1.26T-$193.48B
FQ-2$595.12B-$947.34B-$729.99B
FQ-3$416.57B-$394.00B-$340.78B
FQ-4$1.54T-$2.26T-$1.22T
FQ-5$1.33T-$1.85T-$748.16B
FQ-6$840.19B-$1.33T-$420.18B
FQ-7$224.29B-$701.02B-$454.83B
Valuation
Market price$81900.00
Market cap$3.45T
Enterprise value$11.20T
P/E
Reported non-GAAP P/E
EV/Revenue0.6
EV/Op income
EV/OCF22.9
P/B0.3
P/Tangible book0.3
Tangible book$12.58T
Net cash-$7.75T
Current ratio1.0
Debt/Equity0.8
ROA-6.6%
ROE-16.2%
Cash conversion-24.0%
CapEx/Revenue-8.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric011170Activity
Op margin-10.9%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-11.0%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin1.4%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-8.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity76.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target105,235.29 KRW
Median price target110,000.00 KRW
High price target165,000.00 KRW
Low price target55,000.00 KRW
Mean recommendation2.24 (1=strong buy, 5=strong sell)
Strong-buy count7.00
Buy count5.00
Hold count6.00
Sell count3.00
Strong-sell count0.00
Mean EPS estimate-13,558.18 KRW
Last actual EPS-48,311.00 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 01:37 UTCJob: d1e16c46